PubRank

Siegfried Segaert

Author PubWeight™ 17.32‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antivirals. J Hepatol 2011 1.60
2 Nephrogenic fibrosing dermopathy: a novel, disabling disorder in patients with renal failure. Nephrol Dial Transplant 2004 1.38
3 A proposed EGFR inhibitor dermatologic adverse event-specific grading scale from the MASCC skin toxicity study group. Support Care Cancer 2010 1.25
4 Vaccinations in patients with immune-mediated inflammatory diseases. Rheumatology (Oxford) 2010 1.10
5 SPCA1 pumps and Hailey-Hailey disease. Biochem Biophys Res Commun 2004 1.08
6 1,25-Dihydroxyvitamin D3 inhibits ultraviolet B-induced apoptosis, Jun kinase activation, and interleukin-6 production in primary human keratinocytes. J Cell Biochem 2003 1.04
7 1,25-Dihydroxyvitamin D3 and analogues protect primary human keratinocytes against UVB-induced DNA damage. J Photochem Photobiol B 2005 1.00
8 Two 14-epi analogues of 1,25-dihydroxyvitamin D3 protect human keratinocytes against the effects of UVB. Arch Dermatol Res 2004 0.90
9 The biological rationale for use of vitamin d analogs in combination with corticosteroids for the topical treatment of plaque psoriasis. J Drugs Dermatol 2013 0.89
10 UVB-induced production of 1,25-dihydroxyvitamin D3 and vitamin D activity in human keratinocytes pretreated with a sterol delta7-reductase inhibitor. J Cell Biochem 2006 0.88
11 Characteristics of Skin Lesions Associated With Anti-Tumor Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease: A Cohort Study. Ann Intern Med 2015 0.86
12 Molecular pathways involved in the anti-apoptotic effect of 1,25-dihydroxyvitamin D3 in primary human keratinocytes. J Cell Biochem 2004 0.85
13 The epidermal vitamin D system and innate immunity: some more light shed on this unique photoendocrine system? Dermatology 2008 0.85
14 Clinical improvement and satisfaction with biologic therapy in patients with severe plaque psoriasis: results of a European cross-sectional observational study. J Dermatolog Treat 2012 0.85
15 Once-weekly administration of etanercept 50 mg improves patient-reported outcomes in patients with moderate-to-severe plaque psoriasis. Dermatology 2009 0.80
16 UVB-induced 1,25(OH)2D3 production and vitamin D activity in intestinal CaCo-2 cells and in THP-1 macrophages pretreated with a sterol Delta7-reductase inhibitor. J Cell Biochem 2006 0.79
17 Dermal fibroblasts pretreated with a sterol Delta7-reductase inhibitor produce 25-hydroxyvitamin D3 upon UVB irradiation. J Photochem Photobiol B 2006 0.76
18 Current practice of therapeutic drug monitoring of biopharmaceuticals in psoriasis patients. Ther Drug Monit 2017 0.76
19 Mass Spectrometry of Flame Figures. Acta Derm Venereol 2015 0.75